CRAs are responsible for monitoring each Informed Consent Form (ICF) for their clinical trials. Since they involve the consent of trial participants, making sure the ICFs are completed correctly and entirely is very important. Paying attention to the details will help CRAs be successful with this task!
Here is a list of crucial items that are part of each ICF and should be reviewed by the CRA.
Ensure the correct version of the informed consent was used and that it has a stamp from the Institutional Review Board (IRB) or Ethics Committee (EC).
Review the pagination to make certain it is correct. Are all pages present? (For example: 1 of 12, 2 of 12, through 12 of 12).
Confirm all required initials and/or signatures are present. This includes the participant, witness, person explaining the consent, and/or the Investigator, depending on the IRB/EC used.
Verify the date corresponds with the date of consent. If the dates don’t match, make sure the site included a note of clarification as documentation.
Ensure any checkboxes for notifying the participant’s Primary Care Physician (PCP) or authorizing any additional sample tests are completed. If the PCP box is checked, make sure the research site has documentation of when the PCP was notified about the participant’s participation in the research study.
Confirm the consent process is documented in the source:
We hope you found these tips to be useful. Download our PDF checklist below to use as a reference when monitoring an ICF.
Get your free copy of 6 Key Items to Look for When Monitoring an Informed Consent Form
For more great ideas and products that help Clinical Research Professionals become more efficient, visit our webshop.
Hurrah! In the end I got a weblog from where I can really obtain valuable information regarding my
study and knowledge. Reply
Aw, this was a really good post. Spending some time and actual effort to generate a
top notch article… but what can I say… I put things
off a lot and never manage to get nearly anything done. Reply